Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The Europe flow cytometry market is projected to reach $2.04 billion by 2035 from $928.3 million in 2024, ...
The global flow cytometry market is expected to witness a CAGR of ~9% during the forecast period. High incidence and ...
Accellix™, a pioneer in automated flow cytometry, and Streck, a recognized leader in quality control materials for flow cytometry, hematology and molecular diagnostics, have announced a strategic ...
Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 EXCALIBER-RRMM study evaluating iberdomide, an investigational cereblon E3 ligase modulator (CELMoD™), combined with standard ...
Years before people develop rheumatoid arthritis, their blood teems with activated immune cells that could serve as ...
After the presentation, a thrilling lottery session took place.
Becton Dickinson (NYSE: BDX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Heartflow disclosed the clearance alongside news that Cigna has become the second national insurer after UnitedHealthcare to ...
Heartflow has secured a new FDA clearance for its artificial intelligence program to analyze the buildup of dangerous plaques ...
LCGC International spoke to Maria Hayder, corresponding author of a recently published paper (1) discussing a novel workflow ...
3don MSN
Multi-scale analysis reveals FGFR1 inhibition as effective strategy against cardiac fibrosis
Through a comprehensive approach combining transcriptomic profiling, histological analysis, and functional validation in ...
Report by Towards Healthcare, a sister firm of Precedence ResearchOttawa, Sept. 19, 2025 (GLOBE NEWSWIRE) -- The global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback